Innovative Leukemia and Lymphoma Therapy gives a complete and up-to-date overview of the exciting new treatment modalities in leukemia and lymphoma that are being introduced in the clinic today. Written » ...mai mult
Autor(i): Theodore Warkentin, Andreas Greinacher Editura: Informa Healthcare - 2007 Disponibilitate: la comandă
Preţ: 635,00 lei
Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most potentially devastating and frequent adverse drug reactions encountered by physicians. This Fourth » ...mai mult
Autor(i): John Bennett, Richard Silver, Ayalew Tefferi Editura: Informa Healthcare - 2007 Disponibilitate: la comandă
Preţ: 550,00 lei
With the recent discovery of JAK2 mutations in myeloproliferative disorders medical science has taken a revolutionary stride forward toward understanding the pathogenesis of these disorders. This new advancement » ...mai mult
Multiple myeloma is the second most prevalent hematological malignancy, with over 55,000 new cases diagnosed each year. This exciting reference, edited by lauded authorities on the topic, stands as the » ...mai mult